Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension.
- DOI
- 10.1016/s1474-4422(13)70239-4
- Published
- 2013 Dec
- Container
- The Lancet. Neurology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s1474-4422-13-70239-4,
title = {Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension.},
author = {Trenkwalder C and Beneš H and Grote L and García-Borreguero D and Högl B and Hopp M and Bosse B and Oksche A and Reimer K and Winkelmann J and Allen RP and Kohnen R and RELOXYN Study Group},
year = {2013},
journal = {The Lancet. Neurology},
doi = {10.1016/s1474-4422(13)70239-4},
url = {https://doi.org/10.1016/s1474-4422(13)70239-4}
}RIS
TY - JOUR TI - Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension. AU - Trenkwalder C AU - Beneš H AU - Grote L AU - García-Borreguero D AU - Högl B AU - Hopp M AU - Bosse B AU - Oksche A AU - Reimer K AU - Winkelmann J AU - Allen RP AU - Kohnen R AU - RELOXYN Study Group PY - 2013 JO - The Lancet. Neurology DO - 10.1016/s1474-4422(13)70239-4 UR - https://doi.org/10.1016/s1474-4422(13)70239-4 ER -
APA
C, T., H, B., L, G., D, G., B, H., M, H., B, B., A, O., K, R., J, W., RP, A., R, K., & Group, R. S. (2013). Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension.. The Lancet. Neurology. https://doi.org/10.1016/s1474-4422(13)70239-4
Source records
- pubmed · retrieved 2026-09-26T21:53:14.403Z